Data / Form D filings / Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc.: Form D filings
Praesidia Biotherapeutics, Inc., a biotechnology company in Arlington, MA, filed 5 Form D notices with the SEC between 2021 and 2024. The latest, on July 17, 2024, reports $7.4 million sold of a $15 million offering to 52 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1167 MASSACHUSETTS AVE., Arlington, MA, 02476
- Phone
- (617) 977-5445
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1877990
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2024 | Amendment | $15,000,000 | $7,420,000 | $7,580,000 | 52 | Mar 25, 2024 | sec.gov |
| Apr 11, 2024 | Amendment | $15,000,000 | $5,000,000 | $10,000,000 | 1 | Mar 25, 2024 | sec.gov |
| Apr 8, 2024 | New notice | $15,000,000 | $500,000 | $14,500,000 | 1 | Mar 25, 2024 | sec.gov |
| Aug 23, 2022 | Amendment | $10,000,000 | $4,000,000 | $6,000,000 | 55 | Jul 30, 2021 | sec.gov |
| Aug 12, 2021 | New notice | $10,000,000 | $4,000,000 | $6,000,000 | 55 | Jul 30, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sohang Chatterjee | Executive Officer, Director | |
| Shawn Titcomb | Director | |
| Pradip Majumder | Executive Officer | |
| Martin Lehr | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 15, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Praesidia Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.